Century Therapeutics
IPSC
63 hedge funds and large institutions have $59.6M invested in Century Therapeutics in 2023 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 7 closing their positions.
1,500% more call options, than puts
Call options by funds: $16K | Put options by funds: $1K
114% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 7
65% more capital invested
Capital invested by funds: $36.1M → $59.6M (+$23.5M)
16% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 19
15% more funds holding
Funds holding: 55 → 63 (+8)
0.21% less ownership
Funds ownership: 30.22% → 30.01% (-0.21%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.94M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$467K |
| 3 |
Morgan Stanley
New York
|
+$429K |
| 4 |
Millennium Management
New York
|
+$253K |
| 5 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$87.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.66M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$1.09M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$641K |
| 4 |
BlackRock
New York
|
-$139K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$128K |
IPSC Hedge Fund Activity: Q4 2023 in Review
63 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Century Therapeutics (IPSC) for Q4 2023, worth a combined $59.6M — up 65% from $36.1M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new IPSC positions and 7 closed out — a net gain of 8 holders — while 22 added to existing stakes and 19 trimmed.
The largest buyer was Tang Capital Management, opening a new position worth an estimated $1.94M. The largest seller was Fidelity Investments, cutting an estimated $1.66M.
- 63 institutional investors held Century Therapeutics (IPSC) as of Q4 2023, up from 55 in Q3 2023.
- Funds reported $59.6M of Century Therapeutics stock for Q4 2023, up 65% quarter-over-quarter.
- 15 funds opened new Century Therapeutics positions in Q4 2023 and 7 closed out, a net change of +8 holders.
- The largest Century Therapeutics buyer in Q4 2023 was Tang Capital Management, an estimated $1.94M added.
- The largest Century Therapeutics seller in Q4 2023 was Fidelity Investments, an estimated $1.66M sold.
Based on aggregated 13F filings for Q4 2023.